scholarly journals Loss of the Rap1 effector RIAM results in leukocyte adhesion deficiency due to impaired β2 integrin function in mice

Blood ◽  
2015 ◽  
Vol 126 (25) ◽  
pp. 2704-2712 ◽  
Author(s):  
Sarah Klapproth ◽  
Markus Sperandio ◽  
Elaine M. Pinheiro ◽  
Monika Prünster ◽  
Oliver Soehnlein ◽  
...  

Key Points RIAM is an essential regulator of β2 integrins on leukocytes. Leukocyte α4β1 integrin is activated in a RIAM-independent manner.

2017 ◽  
Vol 214 (3) ◽  
pp. 851-874 ◽  
Author(s):  
Mark Boras ◽  
Stephanie Volmering ◽  
Arne Bokemeyer ◽  
Jan Rossaint ◽  
Helena Block ◽  
...  

Integrin activation is required for neutrophil functions. Impaired integrin activation on neutrophils is the hallmark of leukocyte adhesion deficiency (LAD) syndrome in humans, characterized by impaired leukocyte recruitment and recurrent infections. The Src kinase–associated phosphoprotein 2 (Skap2) is involved in integrin functions in different leukocyte subtypes. However, the role of Skap2 in β2 integrin activation and neutrophil recruitment is unknown. In this study, we demonstrate the crucial role of Skap2 in regulating actin polymerization and binding of talin-1 and kindlin-3 to the β2 integrin cytoplasmic domain, thereby being indispensable for β2 integrin activation and neutrophil recruitment. The direct interaction of Skap2 with the Wiskott–Aldrich syndrome protein via its SH3 domain is critical for integrin activation and neutrophil recruitment in vivo. Furthermore, Skap2 regulates integrin-mediated outside-in signaling events and neutrophil functions. Thus, Skap2 is essential to activate the β2 integrins, and loss of Skap2 function is sufficient to cause a LAD-like phenotype in mice.


1997 ◽  
Vol 56 ◽  
pp. 44
Author(s):  
Taco Kuijpers ◽  
René van Lier ◽  
Dorthe Hamann ◽  
Ron Weening ◽  
Arthur Verhoeven ◽  
...  

Blood ◽  
2005 ◽  
Vol 105 (1) ◽  
pp. 170-177 ◽  
Author(s):  
Patricia P. E. M. Spijkers ◽  
Paula da Costa Martins ◽  
Erik Westein ◽  
Carl G. Gahmberg ◽  
Jaap J. Zwaginga ◽  
...  

Abstract β2-Integrin clustering on activation is a key event in leukocyte adhesion to the endothelium during the inflammatory response. In the search for molecular mechanisms leading to this clustering, we have identified low-density lipoprotein (LDL) receptor–related protein (LRP) as a new partner for β2-integrins at the leukocyte surface. Immobilized recombinant LRP fragments served as an adhesive surface for blood-derived leukocytes and the U937 cell line. This adhesion was decreased up to 95% in the presence of antibodies against β2-integrins, pointing to these integrins as potential partners for LRP. Using purified proteins, LRP indeed associated with the αMβ2 complex and the αM and αL I-domains (Kd, app ≈ 0.5 μM). Immunoprecipitation experiments and confocal microscopy revealed that endogenously expressed LRP and αLβ2 colocalized in monocytes and U937 cells. Furthermore, activation of U937 cells resulted in clustering of αLβ2 and LRP to similar regions at the cell surface, indicating potential cooperation between both proteins. This was confirmed by the lack of αLβ2 clustering in U937 cells treated by antisense oligonucleotides to down-regulate LRP. In addition, the absence of LRP resulted in complete abrogation of β2-integrin–dependent adhesion to endothelial cells in a perfusion system, demonstrating the presence of a previously unrecognized link between LRP and leukocyte function.


1998 ◽  
Vol 188 (6) ◽  
pp. 1029-1037 ◽  
Author(s):  
Andreas E. May ◽  
Sandip M. Kanse ◽  
Leif R. Lund ◽  
Roland H. Gisler ◽  
Beat A. Imhof ◽  
...  

The urokinase receptor (CD87; uPAR) is found in close association with β2 integrins on leukocytes. We studied the functional consequence of this association for leukocyte adhesion and migration. In vivo, the β2 integrin–dependent recruitment of leukocytes to the inflamed peritoneum of uPAR-deficient mice was significantly reduced as compared with wild-type animals. In vitro, β2 integrin–mediated adhesion of leukocytes to endothelium was lost upon removal of uPAR from the leukocyte surface by phosphatidyl-inositol–specific phospholipase C. Leukocyte adhesion was reconstituted when soluble intact uPAR, but not a truncated form lacking the uPA-binding domain, was allowed to reassociate with the cell surface. uPAR ligation with a monoclonal antibody induced adhesion of monocytic cells and neutrophils to vascular endothelium by six- to eightfold, whereas ligation with inactivated uPA significantly reduced cell-to-cell adhesion irrespective of the β2 integrin–stimulating pathway. These data indicate that β2 integrin–mediated leukocyte–endothelial cell interactions and recruitment to inflamed areas require the presence of uPAR and define a new phenotype for uPAR-deficient mice. Moreover, uPAR ligation differentially modulates leukocyte adhesion to endothelium and provides novel targets for therapeutic strategies in inflammation-related vascular pathologies.


2020 ◽  
Vol 21 (4) ◽  
pp. 1402 ◽  
Author(s):  
Monika Bednarczyk ◽  
Henner Stege ◽  
Stephan Grabbe ◽  
Matthias Bros

β2 integrins are heterodimeric surface receptors composed of a variable α (CD11a-CD11d) and a constant β (CD18) subunit and are specifically expressed by leukocytes. The α subunit defines the individual functional properties of the corresponding β2 integrin, but all β2 integrins show functional overlap. They mediate adhesion to other cells and to components of the extracellular matrix (ECM), orchestrate uptake of extracellular material like complement-opsonized pathogens, control cytoskeletal organization, and modulate cell signaling. This review aims to delineate the tremendous role of β2 integrins for immune functions as exemplified by the phenotype of LAD-I (leukocyte adhesion deficiency 1) patients that suffer from strong recurrent infections. These immune defects have been largely attributed to impaired migratory and phagocytic properties of polymorphonuclear granulocytes. The molecular base for this inherited disease is a functional impairment of β2 integrins due to mutations within the CD18 gene. LAD-I patients are also predisposed for autoimmune diseases. In agreement, polymorphisms within the CD11b gene have been associated with autoimmunity. Consequently, β2 integrins have received growing interest as targets in the treatment of autoimmune diseases. Moreover, β2 integrin activity on leukocytes has been implicated in tumor development.


Immunobiology ◽  
2020 ◽  
Vol 225 (3) ◽  
pp. 151938
Author(s):  
Hamid Nawaz Tipu ◽  
Rubab Raza ◽  
Sadaf Jaffar ◽  
Alamgir Khan ◽  
Muhammad Zeeshan Anwar ◽  
...  

Blood ◽  
2001 ◽  
Vol 97 (3) ◽  
pp. 767-776 ◽  
Author(s):  
Estelle S. Harris ◽  
Ann O. Shigeoka ◽  
Wenhua Li ◽  
Roberta H. Adams ◽  
Stephen M. Prescott ◽  
...  

Abstract Leukocyte adhesion deficiency type I (LAD-1) is a disorder associated with severe and recurrent bacterial infections, impaired extravascular targeting and accumulation of myeloid leukocytes, altered wound healing, and significant morbidity that is caused by absent or greatly diminished surface expression of integrins of the β2 class. We report clinical features and analysis of functions of cells from a patient with a myelodysplastic syndrome and infectious complications similar to those in the severe form of LAD-1, but whose circulating neutrophils displayed normal levels of β2 integrins. Analysis of adhesion of these cells to immobilized ligands and to endothelial cells and assays of cell-cell aggregation and chemotaxis demonstrated a profound defect in adhesion mediated by β2 integrins indicative of a variant form of LAD-1. A novel cell line established from Epstein-Barr virus–transformed lymphoblasts from the subject demonstrated deficient β2 integrin–dependent adhesive function similar to that of the primary leukocytes. In addition, these cells had markedly impaired β1 integrin–dependent adhesion. Sequence analysis and electrophoretic mobility of β1 and β2 proteins from the cell line demonstrated that the defects were not a result of structural abnormalities in the integrin subunit chains themselves and suggest that the adhesive phenotype of these cells is due to one or more abnormalities of inside-out signaling mechanisms that regulate the activity of integrins of these classes. These features define a unique LAD-1 variant syndrome that may reveal important insights that are generally relevant to inside-out signaling of integrins, a molecular process that is as yet incompletely understood.


1999 ◽  
Vol 103 (1) ◽  
pp. 97-106 ◽  
Author(s):  
Nancy Hogg ◽  
Mairi P. Stewart ◽  
Sarah L. Scarth ◽  
Rebecca Newton ◽  
Jacqueline M. Shaw ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document